PETALING JAYA: The National Pharmaceutical Regulatory Agency (NPRA) says 57 from a total of 58 adverse events following immunisation (AEFI) reports involving children between the ages of five and 11 it receives as of Monday (Feb 21) were not serious.
NPRA director Dr Roshayati Mohamad Sani said the patient with the serious condition was hospitalised and had since been discharged.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
